問卷

TPIDB > Principal Investigator

Principal Investigator


E-DA Hospital (在職)

Division of Nephrology

更新時間:2023-09-19

紀伯叡
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2020-03-31 - 2022-11-30

Phase II

Completed
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy and Safety of VIS649 in Participants with Immunoglobulin A (IgA) Nephropathy
  • Condition/Disease

    Immunoglobulin A (IgA) Nephropathy

  • Test Drug

    VIS649

Participate Sites
6Sites

Not yet recruiting2Sites

Recruiting3Sites

Study ended1Sites